{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:56:07Z","timestamp":1791212167057,"version":"4.1.0"},"reference-count":46,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2014,3,17]],"date-time":"2014-03-17T00:00:00Z","timestamp":1395014400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0092359","type":"journal-article","created":{"date-parts":[[2014,3,17]],"date-time":"2014-03-17T16:59:53Z","timestamp":1395075593000},"page":"e92359","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Systemic but No Local Effects of Combined Zoledronate and Parathyroid Hormone Treatment in Experimental Autoimmune Arthritis"],"prefix":"10.1371","volume":"9","author":[{"given":"Kresten Krarup","family":"Keller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper Skovhus","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian","family":"Stengaard-Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen-Margrethe","family":"Hauge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,3,17]]},"reference":[{"key":"ref1","first-page":"943","article-title":"Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis","volume":"152(4)","author":"EM Gravallese","year":"1998","journal-title":"Am J Pathol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1359\/jbmr.090320","article-title":"Osteoblast function is compromised at sites of focal bone erosion in inflammatory arthritis","volume":"24(9)","author":"NC Walsh","year":"2009","journal-title":"J Bone Miner Res"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e53034","DOI":"10.1371\/journal.pone.0053034","article-title":"Bone formation and resorption are both increased in experimental autoimmune arthritis","volume":"7(12)","author":"KK Keller","year":"2012","journal-title":"PLoS One"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nm1538","article-title":"Dickkopf-1 is a master regulator of joint remodeling","volume":"13(2)","author":"D Diarra","year":"2007","journal-title":"Nat Med"},{"key":"ref5","first-page":"S","article-title":"Is remission in rheumatoid arthritis associated with radiographic healing?","volume":"24(6","author":"R Rau","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00198-010-1319-x","article-title":"Osteoporosis in inflammatory joint diseases","volume":"22(2)","author":"C Roux","year":"2011","journal-title":"Osteoporos Int"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1002\/art.22117","article-title":"Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis","volume":"54(10)","author":"TP van Staa","year":"2006","journal-title":"Arthritis Rheum"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1002\/art.27592","article-title":"Similar effects of disease-modifying antirheumatic drugs, glucocorticoids, and biologic agents on radiographic progression in rheumatoid arthritis: Meta-analysis of 70 randomized placebo-controlled or drug-controlled studies, including 112 comparisons","volume":"62(10)","author":"N Graudal","year":"2010","journal-title":"Arthritis Rheum"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1210\/jc.2012-1027","article-title":"Benefits and risks of bisphosphonate therapy for osteoporosis","volume":"97(7)","author":"S Khosla","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1517\/14656566.2011.562201","article-title":"Zoledronic acid for prevention and treatment of osteoporosis","volume":"12(5)","author":"C Recknor","year":"2011","journal-title":"Expert Opin Pharmacother"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/MED.0b013e32831a46d6","article-title":"Parathyroid hormone treatment for osteoporosis","volume":"15(6)","author":"F Cosman","year":"2008","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/nature02119","article-title":"Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice","volume":"426(6965)","author":"N Sakaguchi","year":"2003","journal-title":"Nature"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1172\/JCI200421795","article-title":"Distinct contribution of IL-6, TNF-alpha, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice","volume":"114(4)","author":"H Hata","year":"2004","journal-title":"J Clin Invest"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1084\/jem.20062259","article-title":"T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ th cells that cause autoimmune arthritis","volume":"204(1)","author":"K Hirota","year":"2007","journal-title":"J Exp Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00011-006-5208-x","article-title":"Cytokine production profile of splenocytes derived from zymosan A-treated SKG mice developing arthritis","volume":"55(8)","author":"K Kobayashi","year":"2006","journal-title":"Inflamm Res"},{"key":"ref16","first-page":"475","article-title":"Chronic arthritis directly induces quantitative and qualitative bone disturbances leading to compromised biomechanical properties","volume":"27(3)","author":"J Caetano-Lopes","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"R9","DOI":"10.1186\/ar2908","article-title":"Chronic arthritis leads to disturbances in the bone collagen network","volume":"12(1)","author":"J Caetano-Lopes","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"ref18","first-page":"536","article-title":"Histological changes in chronic autoimmune SKG-arthritis evaluated by quantitative three-dimensional stereological estimators","volume":"29(3)","author":"KK Keller","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00296-012-2500-7","article-title":"SKG arthritis as a model for evaluating therapies in rheumatoid arthritis with special focus on bone changes","volume":"33(5)","author":"KK Keller","year":"2013","journal-title":"Rheumatol Int"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1084\/jem.20092301","article-title":"Complement drives Th17 cell differentiation and triggers autoimmune arthritis","volume":"207(6)","author":"M Hashimoto","year":"2010","journal-title":"J Exp Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0002-9440(10)63144-6","article-title":"Repair of local bone erosions and reversal of systemic bone loss upon therapy with anti-tumor necrosis factor in combination with osteoprotegerin or parathyroid hormone in tumor necrosis factor-mediated arthritis","volume":"164(2)","author":"K Redlich","year":"2004","journal-title":"Am J Pathol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1002\/art.20384","article-title":"Zoledronic acid protects against local and systemic bone loss in tumor necrosis factor-mediated arthritis","volume":"50(7)","author":"P Herrak","year":"2004","journal-title":"Arthritis Rheum"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/(SICI)1097-0185(199609)246:1<39::AID-AR5>3.0.CO;2-A","article-title":"Trabecular and endocortical bone surfaces in the rat: Modeling or remodeling?","volume":"246(1)","author":"RG Erben","year":"1996","journal-title":"Anat Rec"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-2818.1986.tb04282.x","article-title":"Estimation of surface area from vertical sections","volume":"3)","author":"AJ Baddeley","year":"1986","journal-title":"J Microsc 142(Pt"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2818.1987.tb02837.x","article-title":"The efficiency of systematic sampling in stereology and its prediction","volume":"3)","author":"HJ Gundersen","year":"1987","journal-title":"J Microsc 147(Pt"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jbmr.1805","article-title":"Standardized nomenclature, symbols, and units for bone histomorphometry: A 2012 update of the report of the ASBMR histomorphometry nomenclature committee","volume":"28(1)","author":"DW Dempster","year":"2013","journal-title":"J Bone Miner Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S8756-3282(99)00194-5","article-title":"Missing observations in bone histomorphometry on osteoporosis: Implications and suggestions for an approach","volume":"25(4)","author":"E Hauge","year":"1999","journal-title":"Bone"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S8756-3282(98)00169-0","article-title":"Additive effect of voluntary exercise and growth hormone treatment on bone strength assessed at four different skeletal sites in an aged rat model","volume":"24(2)","author":"L Mosekilde","year":"1999","journal-title":"Bone"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jbmr.141","article-title":"Guidelines for assessment of bone microstructure in rodents using micro-computed tomography","volume":"25(7)","author":"ML Bouxsein","year":"2010","journal-title":"J Bone Miner Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2818.2005.01469.x","article-title":"Stereological measures of trabecular bone structure: Comparison of 3D micro computed tomography with 2D histological sections in human proximal tibial bone biopsies","volume":"2)","author":"JS Thomsen","year":"2005","journal-title":"J Microsc 218(Pt"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"R185","DOI":"10.1186\/ar2877","article-title":"A combination of methotrexate and zoledronic acid prevents bone erosions and systemic bone mass loss in collagen induced arthritis","volume":"11(6)","author":"B Le Goff","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/art.21824","article-title":"Preliminary evidence for a structural benefit of the new bisphosphonate zoledronic acid in early rheumatoid arthritis","volume":"54(5)","author":"SJ Jarrett","year":"2006","journal-title":"Arthritis Rheum"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1002\/art.20382","article-title":"Targeting osteoclasts with zoledronic acid prevents bone destruction in collagen-induced arthritis","volume":"50(7)","author":"NA Sims","year":"2004","journal-title":"Arthritis Rheum"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jbspin.2005.10.019","article-title":"Bisphosphonate therapy in rheumatoid arthritis","volume":"73(4)","author":"V Breuil","year":"2006","journal-title":"Joint Bone Spine"},{"key":"ref35","first-page":"114","article-title":"Effect of oral clodronate on structural damage and bone turnover in rheumatoid arthritis","volume":"30(1)","author":"H Valleala","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.berh.2005.06.008","article-title":"Bone loss in inflammatory arthritis: Mechanisms and therapeutic approaches with bisphosphonates","volume":"19(6)","author":"E Romas","year":"2005","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/art.23417","article-title":"Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial","volume":"58(5)","author":"SB Cohen","year":"2008","journal-title":"Arthritis Rheum"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1002\/art.20728","article-title":"Effect of intermittent administration of human parathyroid hormone on bone mineral density and arthritis in rats with collagen-induced arthritis","volume":"50(12)","author":"S Fukata","year":"2004","journal-title":"Arthritis Rheum"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1002\/art.21021","article-title":"Additive bone-protective effects of anabolic treatment when used in conjunction with RANKL and tumor necrosis factor inhibition in two rat arthritis models","volume":"52(5)","author":"G Schett","year":"2005","journal-title":"Arthritis Rheum"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P","article-title":"Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor","volume":"43(2)","author":"EM Gravallese","year":"2000","journal-title":"Arthritis Rheum"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/S0002-9440(10)63016-7","article-title":"TRANCE\/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis","volume":"159(5)","author":"AR Pettit","year":"2001","journal-title":"Am J Pathol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"R226","DOI":"10.1186\/ar4065","article-title":"Synovial DKK1 expression is regulated by local glucocorticoid metabolism in inflammatory arthritis","volume":"14(5)","author":"R Hardy","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa031975","article-title":"The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis","volume":"349(13)","author":"DM Black","year":"2003","journal-title":"N Engl J Med"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1210\/jc.2008-2719","article-title":"Effects of teriparatide in postmenopausal women with osteoporosis on prior alendronate or raloxifene: Differences between stopping and continuing the antiresorptive agent","volume":"94(10)","author":"F Cosman","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/jbmr.238","article-title":"Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1\u201334)] in postmenopausal osteoporosis","volume":"26(3)","author":"F Cosman","year":"2011","journal-title":"J Bone Miner Res"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1210\/jc.2012-1844","article-title":"Six months of parathyroid hormone (1\u201384) administered concurrently versus sequentially with monthly ibandronate over two years: The PTH and ibandronate combination study (PICS) randomized trial","volume":"97(10)","author":"AL Schafer","year":"2012","journal-title":"J Clin Endocrinol Metab"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0092359","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T09:32:58Z","timestamp":1540287178000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0092359"}},"subtitle":[],"editor":[{"given":"Dominique","family":"Heymann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,3,17]]},"references-count":46,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,3,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0092359","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,17]]}}}